Relationship between Substantia Nigra Neuromelanin Imaging and Dual Alpha-Synuclein Labeling of Labial Minor in Salivary Glands in Isolated Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.
Parkinson’s disease
alpha-Synuclein
immunostaining
microscopy
minor salivary gland biopsy
neuromelanin
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
24 Sep 2022
24 Sep 2022
Historique:
received:
27
07
2022
revised:
16
09
2022
accepted:
21
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
We investigated the presence of misfolded alpha-Synuclein (α-Syn) in minor salivary gland biopsies in relation to substantia nigra pars compacta (SNc) damage measured using magnetic resonance imaging in patients with isolated rapid eye movement sleep behavior disorder (iRBD) and Parkinson's disease (PD) as compared to healthy controls. Sixty-one participants (27 PD, 16 iRBD, and 18 controls) underwent a minor salivary gland biopsy and were scanned using a 3 Tesla MRI. Deposits of α-Syn were found in 15 (55.6%) PD, 7 (43.8%) iRBD, and 7 (38.9%) controls using the anti-aggregated α-Syn clone 5G4 antibody and in 4 (14.8%) PD, 3 (18.8%) iRBD and no control using the purified mouse anti-α-Syn clone 42 antibody. The SNc damages obtained using neuromelanin-sensitive imaging did not differ between the participants with versus without α-Syn deposits (irrespective of the antibodies and the disease group). Our study indicated that the α-Syn detection in minor salivary gland biopsies lacks sensitivity and specificity and does not correlate with the SNc damage, suggesting that it cannot be used as a predictive or effective biomarker for PD.
Identifiants
pubmed: 36292600
pii: genes13101715
doi: 10.3390/genes13101715
pmc: PMC9601642
pii:
doi:
Substances chimiques
alpha-Synuclein
0
neuromelanin
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Parkinsonism Relat Disord. 2017 May;38:99-101
pubmed: 28259622
Neurosci Lett. 2013 Sep 13;551:62-4
pubmed: 23880024
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
pubmed: 2841426
Acta Neuropathol. 2012 Jul;124(1):37-50
pubmed: 22370907
Eur J Neurol. 2018 Jul;25(7):949-e73
pubmed: 29520900
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Neurol Sci. 2015 Sep;36(9):1575-80
pubmed: 25820147
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
AJNR Am J Neuroradiol. 2018 Aug;39(8):1460-1467
pubmed: 29954816
Neurology. 2014 Mar 11;82(10):858-64
pubmed: 24500652
Mov Disord. 2021 Jul;36(7):1592-1602
pubmed: 33751655
Eur J Neurol. 2016 Feb;23(2):247-61
pubmed: 26100920
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Eur J Neurol. 2016 Feb;23(2):368-74
pubmed: 26518135
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Sleep Med Rev. 2020 Jun;51:101283
pubmed: 32187564
Lancet Neurol. 2016 Jun;15(7):708-718
pubmed: 27039162
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94
pubmed: 17911161
Mov Disord. 2016 Feb;31(2):250-6
pubmed: 26799362
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Brain. 1991 Oct;114 ( Pt 5):2283-301
pubmed: 1933245
Chest. 2014 Nov;146(5):1387-1394
pubmed: 25367475
Mov Disord. 2011 Aug 1;26(9):1633-8
pubmed: 21491489
Nat Rev Neurol. 2013 Jan;9(1):13-24
pubmed: 23183883
Sleep. 2017 Nov 1;40(11):
pubmed: 28958075
Acta Neuropathol. 2010 Jun;119(6):703-13
pubmed: 20229352
J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6
pubmed: 23334596
Mov Disord. 2011 Jan;26(1):188-90
pubmed: 20836135
Lancet Neurol. 2021 Aug;20(8):671-684
pubmed: 34302789
Sleep. 2018 Aug 1;41(8):
pubmed: 29790977